Views & Analysis SMA Awareness Month: How pharma and digital solutions can im... Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
